Evidence map›Paper›PMID 34172278›Full record

ArticleBiological psychiatry2021

Brain Correlates of Suicide Attempt in 18,925 Participants Across 18 International Cohorts.

Adrian I Campos, Paul M Thompson, Dick J Veltman, Elena Pozzi, Laura S van Veltzen, Neda Jahanshad, Mark J Adams, Bernhard T Baune, Klaus Berger, Katharina Brosch and 54 more

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 4 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Revealing the Mechanism ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

64 authors at 20 institutions in 7 countries.

Adrian I CamposGenetic Epidemiology Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Paul M ThompsonImaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, California.
Dick J VeltmanAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, the Netherlands.
Elena PozziDepartment of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
Laura S van VeltzenDepartment of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
Neda JahanshadImaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, California.
Mark J AdamsDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Bernhard T BauneDepartment of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, Victoria, Australia; Department of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
Klaus BergerInstitute of Epidemiology and Social Medicine, University of Münster, Münster, North Rhine-Westphalia, Germany.
Katharina BroschDepartment of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
Robin BülowInstitute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany.
Colm G ConnollyDepartment of Biomedical Sciences, Florida State University, Tallahassee, Florida.
Udo DannlowskiDepartment of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
Christopher G DaveyDepartment of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.
Greig I de ZubicarayInstitute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Danai DimaDepartment of Psychology, School of Arts and Social Sciences, City, University of London, London, United Kingdom; Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Tracy Erwin-GrabnerLaboratory of Systems Neuroscience and Imaging in Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Göttingen, Lower Saxony, Germany.
Jennifer W EvansExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.
Cynthia H Y FuCentre for Affective Disorders, Institute of Psychology, Psychiatry and Neuroscience, King's College London, London, United Kingdom; School of Psychology, University of East London, London, United Kingdom.
Ian H GotlibDepartment of Psychology, Stanford University, Stanford, California.
Roberto Goya-MaldonadoLaboratory of Systems Neuroscience and Imaging in Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Göttingen, Lower Saxony, Germany.
Hans J GrabeGerman Center for Neurodegenerative Disease, Greifswald, Mecklenburg-Vorpommern, Germany.
Dominik GrotegerdDepartment of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
Matthew A HarrisDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Ben J HarrisonDepartment of Psychiatry, The University of Melbourne & Melbourne Health, Melbourne, Victoria, Australia.
Sean N HattonBrain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
Marco HermesdorfInstitute of Epidemiology and Social Medicine, University of Münster, Münster, North Rhine-Westphalia, Germany.
Ian B HickieBrain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
Tiffany C HoDepartment of Psychiatry & Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California.
Tilo KircherDepartment of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
Axel KrugDepartment of Psychiatry and Psychotherapy, University of Bonn, Bonn, North Rhine-Westphalia, Germany; Department of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
Jim LagopoulosThompson Institute, University of the Sunshine Coast, Sunshine Coast, Queensland, Australia; Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
Hannah LemkeDepartment of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
Katie McMahonHerston Imaging Research Facility & School of Clinical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.
Frank P MacMasterDepartment of Pediatrics and Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Strategic Clinical Network for Addictions and Mental Health, Alberta Health Services, Calgary, Alberta, Canada.
Nicholas G MartinGenetic Epidemiology Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Andrew M McIntoshDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Sarah E MedlandFaculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; Psychiatric Genetics Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Austalia; School of Psychology, The University of Queensland, Brisbane, Queensland, Australia.
Susanne MeinertDepartment of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
Tina MellerDepartment of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
Igor NenadicDepartment of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
Nils OpelDepartment of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
Ronny RedlichDepartment of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
Liesbeth RenemanDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, location AMC, Amsterdam, the Netherlands.
Jonathan ReppleDepartment of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
Matthew D SacchetCenter for Depression, Anxiety, and Stress Research, McLean Hospital, Harvard Medical School, Belmont, Massachusetts.
Simon SchmittDepartment of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
Anouk SchranteeDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, location AMC, Amsterdam, the Netherlands.
Kang SimWest Region, Institute of Mental Health, Buangkok View, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Aditya SinghLaboratory of Systems Neuroscience and Imaging in Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Göttingen, Lower Saxony, Germany.
Frederike SteinDepartment of Psychiatry, Philipps-University Marburg, Marburg, Hesse, Germany.
Lachlan T StrikeQueensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia.
Nic J A van der WeeDepartment of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands; Leiden Institute for Brain and Cognition, Leiden, the Netherlands.
Steven J A van der WerffDepartment of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands; Leiden Institute for Brain and Cognition, Leiden, the Netherlands.
Henry VölzkeInstitute for Community Medicine, University Medicine Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany.
Lena WaltemateDepartment of Psychiatry, University of Münster, Münster, North Rhine-Westphalia, Germany.
Heather C WhalleyDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Katharina WittfeldGerman Center for Neurodegenerative Disease, Greifswald, Mecklenburg-Vorpommern, Germany.
Margaret J WrightQueensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia; Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland, Australia.
Tony T YangDepartment of Psychiatry & Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California.
Carlos A ZarateExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.
Lianne SchmaalOrygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia. Electronic address: lianne.schmaal@unimelb.edu.au.
Miguel E RenteríaGenetic Epidemiology Lab, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. Electronic address: miguel.renteria@qimrberghofer.edu.au.
ENIGMA-MDD Working Group
University of Münster · DEPhilipps University of Marburg · DEThe University of Melbourne · AUThe University of Queensland · AUUniversity of Edinburgh · GBThe University of Sydney · AUUniversitätsmedizin Göttingen · DEAmsterdam University Medical Centers · NLGerman Center for Neurodegenerative Diseases · DELeiden University · NLNational Institutes of Health · USQueensland University of Technology · AUUniversitätsmedizin Greifswald · DEUniversity of California, San Francisco · USUniversity of Southern California · USAlberta Health Services · CAAmsterdam Neuroscience · NLCity, University of London · GBFlorida State University · USHarvard University · US

Funding

Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Psychobiological Mechanisms Underlying the Association Between Early Life Stress and Depression Across AdolescenceR37MH101495 · NIMH · STANFORD UNIVERSITY · PI IAN H GOTLIB · 2018 to 2026
$6.6M
A Cross-Sectional and Longitudinal Functional MRI Study of Adolescent DepressionR01MH085734 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI YANG, TONY TUNG-I · 2010 to 2014
$2.7M
Genetic influences on the brain: A twin imaging studyR01HD050735 · NICHD · QUEENSLAND INSTITUTE OF MEDICAL RESEARCH · PI WRIGHT, MARGARET JANE · 2007 to 2011
$2.6M
A global alliance to unlock brain mechanisms influencing suicidal behaviors through the ENIGMA ConsortiumR01MH117601 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JAHANSHAD, NEDA, SCHMAAL, LIANNE · 2018 to 2021
$1.5M
The Roles of Inflammatory and Glutamatergic Processes in the Neurodevelopmental Mechanisms Underlying Adolescent DepressionK01MH117442 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HO, TIFFANY CHEING · 2018 to 2022
$881k
Neural mechanisms of meditation training in healthy and depressed adolescents: An MRI connectome studyR61AT009864 · NCCIH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TYMOFIYEVA, OLGA, YANG, TONY TUNG-I · 2019 to 2020
$822k
Medical Research Council G0802594Medical Research Council MC_PC_17209NCCIH NIH HHS R61 AT009864NIBIB NIH HHS U54 EB020403NICHD NIH HHS R01 HD050735NIMH NIH HHS K01 MH117442NIMH NIH HHS R01 MH085734NIMH NIH HHS R01 MH117601NIMH NIH HHS R37 MH101495Wellcome TrustWellcome Trust 104036/Z/14/Z
6 · The paper itself

Abstract

backgroundNeuroimaging studies of suicidal behavior have so far been conducted in small samples, prone to biases and false-positive associations, yielding inconsistent results. The ENIGMA-MDD Working Group aims to address the issues of poor replicability and comparability by coordinating harmonized analyses across neuroimaging studies of major depressive disorder and related phenotypes, including suicidal behavior.

methodsHere, we pooled data from 18 international cohorts with neuroimaging and clinical measurements in 18,925 participants (12,477 healthy control subjects and 6448 people with depression, of whom 694 had attempted suicide). We compared regional cortical thickness and surface area and measures of subcortical, lateral ventricular, and intracranial volumes between suicide attempters, clinical control subjects (nonattempters with depression), and healthy control subjects.

resultsWe identified 25 regions of interest with statistically significant (false discovery rate < .05) differences between groups. Post hoc examinations identified neuroimaging markers associated with suicide attempt including smaller volumes of the left and right thalamus and the right pallidum and lower surface area of the left inferior parietal lobe.

conclusionsThis study addresses the lack of replicability and consistency in several previously published neuroimaging studies of suicide attempt and further demonstrates the need for well-powered samples and collaborative efforts. Our results highlight the potential involvement of the thalamus, a structure viewed historically as a passive gateway in the brain, and the pallidum, a region linked to reward response and positive affect. Future functional and connectivity studies of suicidal behaviors may focus on understanding how these regions relate to the neurobiological mechanisms of suicide attempt risk.

Indexed as

Major Depressive DisorderSuicide, AttemptedBrainHumansMagnetic Resonance ImagingNeuroimagingMajor depressive disorderStructural magnetic resonance imagingSuicide attempt

Identifiers

PMID34172278
PMCPMC8324512
OpenAlexW3136155973

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.